PATENT CLAIM ANALYSIS

Application Number: 16196217
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["514", "406000"]

Abstract:
The present application relates to novel compounds of formula (I) to their utility in treating and/or preventing clinical conditions including cardiovascular diseases (CVD), to methods for their therapeutic use, to pharmaceutical compositions containing them and to processes for preparing such compounds.

Claim (Index 5):
The compound of  claim 1 , according to formula (II): or a pharmaceutically acceptable salt thereof, wherein each X 1 , X 2  and X 4  of Ring A is independently CR 5 , CH, or N; wherein at least one of X 1 , X 2  and X 4  in Ring A is N; and X 3  is O, S or NR 6 ; or wherein when X 4  is CR 5  and X 3  is NR 6 , then the R 5  and R 6  may be taken together to form a 5 to 6-membered heterocyclyl ring fused to Ring A, which heterocyclyl may optionally contain an additional heteroatom selected from N, O and S; said fused heterocyclyl may additionally contain a carbonyl or a \u2014S(O) 2  directly adjacent to a heteroatom therein; and may be further substituted with one or two substituents selected from the group consisting of \u2014CH 3  and halo; and R 1 , R 2 , R 4 , R 5  and R 6  are as defined in  claim 1 .

Metadata:
- Claim Count in Document: 27.0
- Percentile: 98.0
- Lexical Diversity: 1.26316
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15571291', '16345016', '14208395', '14584219', '14777492']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8092329208070501
- 35 USC 102 Novelty (BERT): 0.5617065102434543
- Combined Prediction Score: 0.7844802797506905
- Mean Citation Score: 381.063586
- Max Citation Score: 463.3882
- Similarity Product: 307.7379501444817

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test